Valneva SE (VALN) Intangibles (2019 - 2026)
Valneva SE (VALN) posted quarterly Intangibles of $24.6 million for Q1 2026, down 12.06% year-on-year from $28.0 million in Q1 2025, and down 3.21% on a QoQ basis from $25.4 million in Q4 2025.
Valneva SE (VALN) Intangibles (2019 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Intangibles for 8 consecutive years, with $24.6 million the latest figure, recorded in Q1 2026.
- Quarterly Intangibles fell 12.06% year-over-year to $24.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.6 million (down 12.06% YoY) and the FY2025 annual result came in at $25.4 million, down 11.52% from the prior year.
- Intangibles eased to $24.6 million in Q1 2026 per VALN's latest filing, from $25.4 million in the prior quarter.
- Over the last five years, Intangibles for VALN reached as high as $38.1 million in Q3 2024 and fell as low as $24.6 million in Q1 2026.
- A 5-year average of $30.2 million and a median of $29.1 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles grew 27.09% — and 2025, when it plunged 31.08%.
- Year by year, Intangibles stood at $32.7 million in 2022, then decreased by 10.95% to $29.1 million in 2023, then retreated by 1.21% to $28.7 million in 2024, then dropped by 11.52% to $25.4 million in 2025, then retreated by 3.21% to $24.6 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $24.6 million, $25.4 million, and $26.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 24.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.62 Mn |
| Dec 31, 2025 | 25.43 Mn |
| Sep 30, 2025 | 26.26 Mn |
| Jun 30, 2025 | 27.11 Mn |
| Mar 31, 2025 | 27.99 Mn |
| Dec 31, 2024 | 28.74 Mn |
| Sep 30, 2024 | 38.10 Mn |
| Jun 30, 2024 | 27.53 Mn |
| Mar 31, 2024 | 28.28 Mn |
| Dec 31, 2023 | 29.09 Mn |
| Sep 30, 2023 | 29.97 Mn |
| Jun 30, 2023 | 30.87 Mn |
| Mar 31, 2023 | 31.74 Mn |
| Dec 31, 2022 | 32.67 Mn |
| Sep 30, 2022 | 33.74 Mn |
| Jun 30, 2022 | 34.95 Mn |
| Mar 31, 2022 | 36.15 Mn |
| Dec 31, 2021 | 37.21 Mn |
| Dec 31, 2020 | 40.29 Mn |
| Dec 31, 2019 | 47.58 Mn |